Mediator Appointed to Help Settle Roundup Lawsuits Has Overseen Massive Settlement Programs in Recent Years

The U.S. District Judge presiding over all federal Roundup lawsuits has appointed prominent attorney Ken Feinberg to serve as a mediator and help settle claims brought by individuals nationwide who developed non-Hodgkins lymphoma after exposure to the controversial weedkiller.

Feinberg has previously overseen massive settlement programs in a number of high-profile litigations, including funds to pay claims related to the BP oil spill, Volkswagen emissions scandal, General Motors ignition switch recall, September 11th Victim Compensation fund and others.

The move signals continuing pressure on Bayer and its Monsanto subsidiary to start negotiating Roundup settlements in more than 15,000 claims pending nationwide, following a series of high-profile losses at trial, where the company has been ordered to pay billions in compensation so far for failing to warn users about the risk of cancer, or provide proper safety instructions while spraying the weedkiller.

ROUNDUP LAWSUITS

Were you or a loved one exposed to RoundUp?

Exposure to RoundUp has been linked to an increased risk of developing Non-Hodgkin's Lymphoma and other cancers. RoundUp cancer lawsuits are being actively investigated.

Learn More About this Lawsuit See If You Qualify For Compensation

Each of the claims raise similar allegations that the manufacturer knew the glyphosate-based herbicide increases the risk of non-Hodgkins lymphoma, yet continued to market Roundup as safe and engaged in active efforts to prevent regulators from warning consumers.

The first trial was held in California state court last summer, ending in a $289 million jury verdict, which was later reduced to a final judgment of about $78 million following post-trial motions.

A second trial was held in federal court earlier this year, resulting in a verdict of $80 million, despite a format that was widely thought to heavily favor the manufacturer.

Finally, a third trial concluded last week with a landmark $2 billion verdict in California state court, after considering evidence in a lawsuit brought by a husband and wife who were each diagnosed with non-Hodgkins lymphoma following use of Roundup.

In the federal court system, all claims are currently centralized for pretrial proceedings before U.S. District Judge Vince Chhabria in the U.S. District Court for the Northern District of California, as part of a multidistrict litigation (MDL).

According to minutes (PDF) from a case management conference on Wednesday, Judge Chhabria has appointed Feinberg as a private mediator to meet with the parties and see if the Roundup cases can be settled, indicating that a status report should be provided within the next 14 days.

Judge Chhabria has also scheduled the next federal bellwether trial to begin on February 10, 2020, involving a lawsuit filed by a woman diagnosed with non-Hodgkins lymphoma following extensive use of Roundup in her herb garden for years.

0 Comments

Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

BioZorb Lawsuit Alleges Breast Tissue Marker Failed, Requiring Surgical Removal
BioZorb Lawsuit Alleges Breast Tissue Marker Failed, Requiring Surgical Removal (Posted yesterday)

A BioZorb lawsuit has been filed by several breast cancer survivors after the BioZorb implants moved out of place and failed to dissolve int he body, requiring surgical removal.

Fairness Hearing For Philips CPAP Recall Medical Monitoring Settlement Set for October
Fairness Hearing For Philips CPAP Recall Medical Monitoring Settlement Set for October (Posted yesterday)

A U.S. District Court judge has scheduled a fairness hearing for October in order to determine whether final approval should be granted to a $25 million Philips CPAP recall settlement agreement, which would pay former users $25 million to pay for future medical monitoring needs.

Abbott Laboratories Faces Jury Trial Over Claims Similac Caused NEC For Premature Infant
Abbott Laboratories Faces Jury Trial Over Claims Similac Caused NEC For Premature Infant (Posted 2 days ago)

Following a $60 million verdict in a similar lawsuit earlier this year, trial is underway involving claims brought by an Illinois mother, whose premature daughter developed NEC from Similac, alleging that Abbott failed to warn parents and medical staff of the devastating risks associated with the cow's milk-based formula.